Vedran Pavlovic

Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study

Milan J. Sonneveld, Willem Pieter Brouwer, Henry LY Chan et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 73 citations

Medicine, Internal Medicine, Gastroenterology +12

Serum HBV RNA as a Predictor of Peginterferon Alfa-2a Response in Patients With HBeAg-Positive Chronic Hepatitis B

Florian van Bömmel, Alena van Bömmel, A Krauel et al. · The Journal of Infectious Diseases · 2018 · 71 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Xalnesiran with or without an Immunomodulator in Chronic Hepatitis B

Jinlin Hou, Wenhong Zhang, Qing Xie et al. · New England Journal of Medicine · 2024 · 69 citations · Full text

Pharmacy, Immunology, Pharmacology +15

Efficacy and Safety of Peginterferon Alfa‐2a (40KD) in Children With Chronic Hepatitis B: The PEG‐B‐ACTIVE Study

Stefan Wirth, Hongfei Zhang, Winita Hardikar et al. · Hepatology · 2018 · 67 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B

Maria Pfefferkorn, T Schott, Stephan Böhm et al. · Journal of Hepatology · 2020 · 61 citations

Medicine, Internal Medicine, Hepatology +9